Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Thill

Showing results (101-110 of 165) with videos related to

Pageof 17
Sort By:
Anti-Cancer Drugs|March 16, 2019
A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA)Joachim Bischoff, Jana Barinoff, Christoph Mundhenke, et al.
The New England Journal of Medicine|December 12, 2024
Axillary Surgery in Breast Cancer - Primary Results of the INSEMA TrialToralf Reimer, Angrit Stachs, Kristina Veselinovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2019
Prospective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) TrialSherko Kuemmel, Johannes Holtschmidt, Bernd Gerber, et al.
Therapeutic Advances in Medical Oncology|December 7, 2020
The run-in phase of the prospective WSG-ADAPT HR+/HER2- trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancerUlrike Nitz, Oleg Gluz, Hans H Kreipe, et al.
Breast Care (Basel, Switzerland)|December 5, 2019
Treatment of Early Breast Cancer Patients: Evidence, Controversies, Consensus: Focusing on Systemic Therapy - German Experts' Opinions for the 16th International St. Gallen Consensus Conference (Vienna 2019)Diana Lüftner, Ingo Bauerfeind, Michael Braun, et al.
Geburtshilfe Und Frauenheilkunde|February 16, 2022
Update Breast Cancer 2021 Part 5 - Advanced Breast CancerDiana Lüftner, Florian Schütz, Elmar Stickeler, et al.
Geburtshilfe Und Frauenheilkunde|March 14, 2022
Correction: Update Breast Cancer 2021 Part 5 - Advanced Breast CancerDiana Lüftner, Florian Schütz, Elmar Stickeler, et al.
Frontiers in Pharmacology|September 11, 2023
An international comparative analysis and roadmap to sustainable biosimilar marketsKhalid A Alnaqbi, Agnès Bellanger, Alex Brill, et al.
Geburtshilfe Und Frauenheilkunde|September 16, 2022
Axillary Staging after Neoadjuvant Chemotherapy for Initially Node-Positive Breast Carcinoma in Germany: Initial Data from the AXSANA studySteffi Hartmann, Thorsten Kühn, Michael Hauptmann, et al.
Geburtshilfe Und Frauenheilkunde|February 16, 2022
Update Breast Cancer 2021 Part 4 - Prevention and Early StagesChristoph Thomssen, Tanja N Fehm, Elmar Stickeler, et al.
Pageof 17

Showing results (101-110 of 165) with videos related to

Sort By:
Pageof 17
Anti-Cancer Drugs|March 16, 2019
A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA)Joachim Bischoff, Jana Barinoff, Christoph Mundhenke, et al.
The New England Journal of Medicine|December 12, 2024
Axillary Surgery in Breast Cancer - Primary Results of the INSEMA TrialToralf Reimer, Angrit Stachs, Kristina Veselinovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2019
Prospective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) TrialSherko Kuemmel, Johannes Holtschmidt, Bernd Gerber, et al.
Therapeutic Advances in Medical Oncology|December 7, 2020
The run-in phase of the prospective WSG-ADAPT HR+/HER2- trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancerUlrike Nitz, Oleg Gluz, Hans H Kreipe, et al.
Breast Care (Basel, Switzerland)|December 5, 2019
Treatment of Early Breast Cancer Patients: Evidence, Controversies, Consensus: Focusing on Systemic Therapy - German Experts' Opinions for the 16th International St. Gallen Consensus Conference (Vienna 2019)Diana Lüftner, Ingo Bauerfeind, Michael Braun, et al.
Geburtshilfe Und Frauenheilkunde|February 16, 2022
Update Breast Cancer 2021 Part 5 - Advanced Breast CancerDiana Lüftner, Florian Schütz, Elmar Stickeler, et al.
Geburtshilfe Und Frauenheilkunde|March 14, 2022
Correction: Update Breast Cancer 2021 Part 5 - Advanced Breast CancerDiana Lüftner, Florian Schütz, Elmar Stickeler, et al.
Frontiers in Pharmacology|September 11, 2023
An international comparative analysis and roadmap to sustainable biosimilar marketsKhalid A Alnaqbi, Agnès Bellanger, Alex Brill, et al.
Geburtshilfe Und Frauenheilkunde|September 16, 2022
Axillary Staging after Neoadjuvant Chemotherapy for Initially Node-Positive Breast Carcinoma in Germany: Initial Data from the AXSANA studySteffi Hartmann, Thorsten Kühn, Michael Hauptmann, et al.
Geburtshilfe Und Frauenheilkunde|February 16, 2022
Update Breast Cancer 2021 Part 4 - Prevention and Early StagesChristoph Thomssen, Tanja N Fehm, Elmar Stickeler, et al.
Pageof 17